BMRA vs NDAQ · rev $4.5M vs P/E 41, rev $2.53B
Biomerica Inc (BMRA) versus Nasdaq Inc (NDAQ) — a side-by-side from cached financials, not a winner call.
Biomerica Inc (BMRA) is a medical devices company listed on US.
Nasdaq Inc (NDAQ) is a financial data & stock exchanges company listed on US.
Latest reported BMRA revenue for 2026-05-31 was $4.5M. Net income was -$3.8M. Revenue was down 16.2% from 2025-05-31 to 2026-05-31. BMRA currently screens at market cap $8.0M.
Latest reported NDAQ revenue for 2026-06-30 was $2.53B. Net income was $507.0M. Revenue was up 18.5% from 2026-03-31 to 2026-06-30. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
BMRA currently screens at market cap $8.0M. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
Not investment advice. Open the BMRA and NDAQ stock pages for the full models.
Not investment advice.